Top in ID: Cracks in pandemic response; impact of ending COVID-19 emergencies
Click Here to Manage Email Alerts
A review of the CDC’s performance during the COVID-19 pandemic found that the agency was slow to share science and data, struggled to develop practical policies and fell short of prioritizing public health communications.
“For 75 years, the CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations,” CDC Director Rochelle P. Walensky, MD, MPH, said in a statement to the media.
It was the top story in infectious disease last week.
Another top story discussed what the future holds after the expiration of public health and national emergencies related to the COVID-19 pandemic.
Read these and more top stories in infectious disease below:
COVID-19 pandemic tested CDC and FDA, exposing cracks
Last April, Rochelle P. Walensky, MD, MPH, requested an internal and external review of the CDC’s performance during the COVID-19 pandemic. Read more.
What happens after COVID-19 emergencies end?
The public health and national emergencies declared by the United States in the early days of the COVID-19 pandemic expired at the end of the day on May 11. Read more.
First US cases of tinea caused by T. indotineae reported in New York
Health officials identified the first cases of severe tinea, or ringworm, caused by Trichophyton indotineae in the U.S., according to case reports published in MMWR. Read more.
Tennessee E. coli outbreak linked to raw milk from multistate cow-share
An outbreak of Shiga toxin-producing Escherichia coli in Tennessee was caused by raw milk consumption among members of a cow-share, according to a study. Read more.
Q&A: What impact did ID experts have on the COVID-19 pandemic?
Throughout the COVID-19 pandemic, infectious disease experts made contributions to help control the outbreak and improve public understanding of the new disease. Read more.